Contacts

Innovations

Innovations

ANABION can provide innovative original treatment options

biosimilars to most significant drugs and gene therapies used to help patients with diseases in the following therapeutic areas:Oncology, Autoimmune diseases, Rare diseases (such as SMA, hemophilia etc.)

Pipeline

Innovation Pipeline

Our pipeline includes original monoclonal antibodies, biosimilars, gene therapies (AAV-based), and innovative treatment formats for complex conditions. (Psoriasis in children, Crohn’s disease, and systemic lupus erythematosus)
We are actively progressing through regulatory stages in over 20 countries with more than 100 dossiers planned by 2027.
We are actively progressing through regulatory stages in over 20 countries with more than 100 dossiers planned by 2027.
Contacts

Melanoma trials

(Nurulimab + Prolgolimab)

Hemophilia B

(AAV5-FIX)

SMA

(AAV9-SMN1 and small molecule generics)

Contacts